Skip to content

menu

Reed Smith LLP logo
HomeAboutSubscribeTopicsOur ServicesContact
Search
Close

Health Industry Washington Watch

Updates by Reed Smith on U.S. legislative & regulatory developments affecting the health care industry

Draft Part D/MA 2010 Call Letter Rescinded

By Debra A. McCurdy on 27 January 2009
Print:
Email this postTweet this postLike this postShare this post on LinkedIn

CMS has rescinded its draft 2010 Medicare Advantage (MA), Medicare Advantage-Prescription Drug (MA-PD), Cost-Based Plan, and Stand Alone Prescription Drug Plan (PDP) Call Letter so it can be further reviewed by the new Obama Administration. CMS will post a new version of the draft as soon as possible. 

Posted in Other CMS Developments
Tags: Medicare Advantage, Medicare Part D Drugs, Other CMS Developments
Related Posts
CMS levies penalties for non-compliance with Hospital Price Transparency Rule
June 21, 2022
New and improved proposed national coverage determination on screening for lung cancer with low dose CT
November 22, 2021
CMS acknowledges improvement in nursing home COVID-19 response, eliminates certain blanket waivers
April 29, 2021

Subscribe to Health Industry Washington Watch

Updates direct to your inbox
Subscribe by Email

Links & Resources

Key Regulatory Sites

  • CMS
  • FDA
  • Federal Register
  • HHS
  • HHS OIG

Key Legislative Sites

  • Congressional Record
  • House Energy and Commerce Committee
  • House Ways and Means Committee
  • Senate Finance Committee
  • Thomas (Library of Congress)

Health Industry Washington Watch

View Our Network of Blogs
Published by
Reed Smith LLP logo
RSS Twitter Facebook LinkedIn youtube
Privacy PolicyDisclaimer

About Our Firm

Reed Smith represents many of the world’s leading companies in complex litigation and other high-stakes disputes, cross-border and other strategic transactions, and crucial regulatory matters.

Read More...

Topics

Archives

Copyright © 2022, Reed Smith LLP. All Rights Reserved.
Law blog design & platform by LexBlog LexBlog Logo